NUVB
Nuvation Bio Inc
5.00$
-3.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
Nuvation Bio Inc (NUVB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -5.1 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.9 | -3.9 | -7.2 | -9.4 | -8.7 | -6.8 | -8.0 | -13 | -15 | -17 | -13 | -23 | -25 | -27 | -28 | -16 | -19 | -17 | -16 | -15 | -16 | -37 | -31 | -46 | -43 | -48 | -53 | -30 | 5.1 | -5.1 | -83 | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.3 | 0.4 | 0.5 | -1.2 | 0.5 | -0.5 | -0.7 | |
| – | – | – | – | 0.3 | 0.4 | 0.3 | 1.1 | 1.6 | 2.2 | 2.7 | 2.8 | 3.6 | 4.8 | 2.9 | 5.0 | 4.8 | 5.5 | 5.4 | 3.7 | 5.0 | 9.6 | 7.5 | 10 | 7.9 | 12 | 8.0 | -28 | 9.0 | -9.0 | -20 | |
| – | – | – | – | 0.5 | – | 0.4 | 1.5 | 6.2 | 2.8 | 2.6 | 0.8 | -2.5 | 2.4 | 2.7 | 4.8 | 4.8 | 2.6 | 1.6 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | -0.5 | -0.5 | 1.2 | 2.6 | -1.2 | -0.6 | -0.3 | 4.9 | 0.8 | -2.9 | 3.7 | -4.4 | 0.2 | -0.3 | 0.5 | 1.8 | -1.4 | -4.6 | -6.1 | 5.0 | -6.7 | 2.8 | 0.2 | -8.7 | 5.7 | -11 | 11 | -3.0 | |
| 0.0 | 0.0 | 0.3 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | |
| – | – | -123 | 7.2 | 11 | 11 | 6.5 | -98 | -1.1 | -173 | -92 | -189 | -5.6 | 27 | 64 | -22 | -52 | 37 | -9.6 | 33 | 7.5 | 34 | 29 | 52 | 54 | 55 | -97 | 87 | -44 | 6.0 | -47 | |
| – | – | – | – | – | – | 146 | 136 | – | 0.2 | 0.0 | 0.5 | 0.3 | 0.1 | 0.3 | 0.3 | 0.3 | – | – | – | – | – | – | – | – | – | – | – | – | -17 | – | |
| – | – | – | – | – | – | – | – | – | 4.0 | 4.0 | 4.0 | 4.0 | -4.0 | – | – | – | – | – | – | – | – | -3.2 | -2.1 | -0.5 | 49 | 0.0 | 0.0 | 0.0 | 185 | 185 | |
| 73 | 73 | -1.8 | -0.2 | 0.5 | 0.0 | 0.5 | 133 | 625 | 0.1 | 0.0 | 0.5 | 4.3 | -3.6 | 0.3 | 0.4 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | 2.7 | -1.5 | -0.9 | 0.5 | 193 | 0.5 | 8.1 | 0.0 | 171 | 179 | |
| 69 | 69 | -132 | -2.4 | 1.9 | 4.0 | -1.0 | 21 | 609 | -189 | -105 | -212 | -26 | -3.9 | 36 | -38 | -71 | 20 | -26 | 18 | -8.1 | -0.2 | -4.2 | 5.7 | 12 | 200 | -149 | 65 | -39 | 171 | 49 | |
| -3.9 | -3.9 | -7.5 | -9.7 | -8.8 | -6.8 | -8.1 | -13 | -15 | -17 | -13 | -24 | -25 | -27 | -28 | -16 | -19 | -18 | -16 | -15 | -16 | -37 | -31 | -46 | -43 | -48 | -53 | -30 | 5.0 | -5.0 | -83 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.